Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by qwerty22


T.TH

RE:IR and PR filled

It seems to me it's unlikely there will be any retooling before 1902...

July 15, 2022

T.TH

RE:RE:RE:RE:So what if I told you

If one Q they enrolled two people and the next Q they enrolled 3 people then...

July 14, 2022

T.TH

RE:RE:RE:RE:Things to understand about targeted cancer treatment

"I was tired of some cr*p here and still is, but hey, I use the ignore...

July 14, 2022

T.TH

RE:RE:RE:So what if I told you

Egrifta has been a roller coaster. Stoppages, changing hands, reformulation...

July 14, 2022

T.TH

RE:So what if I told you

If you timed how long they spent talking about each part of the business it...

July 14, 2022

T.TH

RE:So what if I told you

I think there's something very odd about the lack of a fanfare about...

July 14, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:Questions

SORT1, a brand new cancer target get's it's first ever human response...

July 14, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:Questions

You have to understand SD is a veryspecific description of how their tumours...

July 14, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:Questions

Yep that was worrying me. Why not shout proof of efficacy in the title of the...

July 14, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:Questions

There's going to be overlapping data coming out from this point forward...

July 14, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Questions

What they've shown is anti-tumour activity. What they next need to show...

July 14, 2022

T.TH

RE:RE:RE:RE:RE:Questions

I think the 53% PR is POC practically and scientifically. It's never 100%...

July 14, 2022

T.TH

RE:RE:RE:RE:Questions

An average of 8 cycles seems very high, higher than I've seen in other...

July 14, 2022

T.TH

RE:RE:RE:RE:RE:Questions

"I am not sure what you think is unclear."   I was trying...

July 14, 2022

T.TH

RE:RE:RE:Questions

One problem is they are essentially still cherry-picking what they want us to...

July 14, 2022

T.TH

RE:RE:A Christain section on oncology

Maybe it's the lack of oncology specialist analysts.  SPCEO1...

July 14, 2022

T.TH

RE:Questions

Seems to me they were quite defensive over oncology. I'm wondering if...

July 14, 2022

T.TH

RE:Questions

Why isn't oncology front and centre. Feels like they couldn't down...

July 14, 2022

T.TH

A Christain section on oncology

would have been nice. Emphasize it's importance.

July 14, 2022

T.TH

RE:Pre Market up 14%

The PR came after 3 cycles!!! What does this tell us? I thought scans...

July 14, 2022

Featured Company